PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,000 | -72.2% | 1,620 | -81.1% | 0.00% | -88.9% |
| Q4 2016 | $18,000 | -30.8% | 8,573 | +12.6% | 0.01% | -40.0% |
| Q3 2016 | $26,000 | +8.3% | 7,614 | 0.0% | 0.02% | +7.1% |
| Q2 2016 | $24,000 | -4.0% | 7,614 | 0.0% | 0.01% | -6.7% |
| Q1 2016 | $25,000 | +31.6% | 7,614 | +102.1% | 0.02% | +25.0% |
| Q3 2015 | $19,000 | -47.2% | 3,768 | -33.6% | 0.01% | -42.9% |
| Q2 2015 | $36,000 | +63.6% | 5,671 | +79.9% | 0.02% | +61.5% |
| Q1 2015 | $22,000 | -24.1% | 3,153 | -15.2% | 0.01% | -27.8% |
| Q4 2014 | $29,000 | -45.3% | 3,717 | -48.1% | 0.02% | -47.1% |
| Q3 2014 | $53,000 | +35.9% | 7,161 | +77.1% | 0.03% | +47.8% |
| Q2 2014 | $39,000 | +14.7% | 4,043 | 0.0% | 0.02% | +9.5% |
| Q1 2014 | $34,000 | +3300.0% | 4,043 | +5150.6% | 0.02% | +2000.0% |
| Q4 2013 | $1,000 | – | 77 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |